Form D · Biotechnology
Vergent Bioscience, Inc.
Minneapolis, MN · CIK 0001741495
Offering snapshot reported Oct 20, 2025 · SEC filing
- Reported sold
- $18.7M Offering amount: $32M
- Investors reported
- 20 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Oct 7, 2025 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Oct 20, 2025 | Initial | $18,673,277 | No comparison | 20 | SEC filing |
| Feb 18, 2025 | Initial | $3,750,000 | No comparison | 5 | SEC filing |
| Feb 18, 2025 | Amendment | $3,750,000 | $0vs Feb 18, 2025 | 5 | SEC filing |
| Oct 4, 2022 | Initial | $21,542,628 | No comparison | 27 | SEC filing |
| Nov 22, 2021 | Initial | $1,163,814 | No comparison | 16 | SEC filing |
| Sep 23, 2020 | Amendment | $11,916,407 | $2,235,794vs Feb 22, 2019 | 21 | SEC filing |
| Feb 22, 2019 | Amendment | $9,680,613 | $1,000,000vs Jun 1, 2018 | 19 | SEC filing |
| Jun 1, 2018 | Initial | $8,680,613 | No comparison | 14 | SEC filing |
Offering details
- Securities
- Equity, Option to acquire, Security to be acquired
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0 (estimated)
- Finders' fees
- $0
- Form D file number
- 021-561371
Amounts include securities issued upon conversion of outstanding promissory notes and warrants authorized for issuance in connection with the offering.
Source: Form D, filed Oct 20, 2025. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Samuel Banks | Director |
| Samuel Dean Banks | Director |
| Ryan Egeland | Director |
| Bobby Helmedag | Director |
| Jeff Julkowski | Director |
| Jeffrey Julkowski | Director, Promoter |
| Douglas Kohrs | Director |
| John Santini | Director, Executive |
| John T. Santini, Jr. | Director, Executive |
| Margo Shoup | Director |
| Anita Watkins | Director |
| Anita Wilson | Director |
| Raymond Wong | Director |
| Jeffrey Yurecko | Executive |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
5810 W 78 Th St Ste 222
Minneapolis, MN, 55439
Minneapolis, MN, 55439